We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Featured News

 

Latest News

Cerep Grants BioPrint® Access to AstraZeneca
News   May 12, 2006

AstraZeneca will have non-exclusive access to physicochemical, pharmacological and clinical data on BioPrint® compounds.

READ MORE

NIEHS Researchers Link Gene Variation to Coronary Heart Disease
News   May 12, 2006

The research builds on a body of evidence suggesting the importance of Caucasians that carries the gene variation.

READ MORE

Nanophase Cosponsors Fifth Annual Nanobusiness Alliance Conference
News   May 12, 2006

Joseph Cross, Nanophase’s president and CEO, will address the conference.

READ MORE

Illinois Grant Supports Stem Cell Research at UIC
News   May 12, 2006

Of the total, $2 million will be used to establish a center for the development of stem cell therapies for human diseases.

READ MORE

Open Biosystems Gains Momentum in European RNAi Market
News   May 12, 2006

Open Biosystems' Open Access RNAi Program provides CIC bioGUNE with shRNAmir technology.

READ MORE

Celera and Collaborators Discover Genetic Markers Associated with Heart Attacks
News   May 12, 2006

The key finding of the study was that variants of the VAMP8 and HNRPUL1 genes were associated with early-onset MI.

READ MORE

Nonlinear Enter Co-Marketing Agreement with Agilent
News   May 11, 2006

The agreement is centred on synergies between the Agilent 2100 bioanalyzer 'lab-on-a-chip' platform and Nonlinear’s TL120 DM software.

READ MORE

Diagenic Presents Test Data for Parkinson Disease at European IPA Meeting
News   May 11, 2006

Study shows peripheral blood-based gene expression assay can be employed to discriminate patients with Parkinson and Alzheimer’s disease.

READ MORE

IDBS Joins SAFE-BioPharma Association’s Vendor Partner Program
News   May 11, 2006

SAFE created and manages the SAFE™ digital identity and signature standard used in the pharmaceutical industry.

READ MORE

Laureate and Iconic Announce Immunoprotein Manufacturing Agreement
News   May 11, 2006

Laureate to cGMP manufacture hI-con1 protein to be used by Iconic in clinical trials for treatment of macular degeneration and cancer.

READ MORE

 
Advertisement